Dr. Charles Irvin suspects that a 50-year-old drug with an expiring patent may prove a cheaper and more effective alternative to some newer, heavily marketed drugs used for asthma. The drug, theophylline, may have useful anti-inflammatory effects similar to steroids when used at dosages of… Read More
Comments for: Asthma researchers tap older, cheaper drug
Asthma researchers tap older, cheaper drug
You may also like
Asthma researchers tap older, cheaper drug